ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s stock price was up 0.8% during trading on Wednesday . The stock traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares changed hands during mid-day trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Trading Up 0.8%
The company has a current ratio of 5.06, a quick ratio of 4.29 and a debt-to-equity ratio of 1.70. The firm has a market cap of C$162.08 million and a PE ratio of -7.30. The company’s 50-day moving average is C$6.50 and its 200 day moving average is C$6.50.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- Growth Stocks: What They Are, What They Are Not
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
